Report Detail
Global (United States, European Union and China) Antibody Drug Conjugates Market Research Report 2019-2025
- RnM3578825 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment.
The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
In 2019, the market size of Antibody Drug Conjugates is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antibody Drug Conjugates.
This report studies the global market size of Antibody Drug Conjugates, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antibody Drug Conjugates sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals
Market Segment by Product Type
Adcetris
Kadcyla
Market Segment by Application
Breast Cancer
Lymphoma
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antibody Drug Conjugates status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antibody Drug Conjugates manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antibody Drug Conjugates are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Antibody Drug Conjugates Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Adcetris
- 1.3.3 Kadcyla
- 1.4 Market Segment by Application
- 1.4.1 Global Antibody Drug Conjugates Market Share by Application (2019-2025)
- 1.4.2 Breast Cancer
- 1.4.3 Lymphoma
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Antibody Drug Conjugates Market Size
- 2.1.1 Global Antibody Drug Conjugates Revenue 2014-2025
- 2.1.2 Global Antibody Drug Conjugates Sales 2014-2025
- 2.2 Antibody Drug Conjugates Growth Rate by Regions
- 2.2.1 Global Antibody Drug Conjugates Sales by Regions 2014-2019
- 2.2.2 Global Antibody Drug Conjugates Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Antibody Drug Conjugates Sales by Manufacturers
- 3.1.1 Antibody Drug Conjugates Sales by Manufacturers 2014-2019
- 3.1.2 Antibody Drug Conjugates Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Antibody Drug Conjugates Revenue by Manufacturers (2014-2019)
- 3.2.2 Antibody Drug Conjugates Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Antibody Drug Conjugates Market Concentration Ratio (CR5 and HHI)
- 3.3 Antibody Drug Conjugates Price by Manufacturers
- 3.4 Key Manufacturers Antibody Drug Conjugates Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Antibody Drug Conjugates Market
- 3.6 Key Manufacturers Antibody Drug Conjugates Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Adcetris Sales and Revenue (2014-2019)
- 4.1.2 Kadcyla Sales and Revenue (2014-2019)
- 4.2 Global Antibody Drug Conjugates Sales Market Share by Type
- 4.3 Global Antibody Drug Conjugates Revenue Market Share by Type
- 4.4 Antibody Drug Conjugates Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Antibody Drug Conjugates Sales by Application
6 United States
- 6.1 United States Antibody Drug Conjugates Breakdown Data by Company
- 6.2 United States Antibody Drug Conjugates Breakdown Data by Type
- 6.3 United States Antibody Drug Conjugates Breakdown Data by Application
7 European Union
- 7.1 European Union Antibody Drug Conjugates Breakdown Data by Company
- 7.2 European Union Antibody Drug Conjugates Breakdown Data by Type
- 7.3 European Union Antibody Drug Conjugates Breakdown Data by Application
8 China
- 8.1 China Antibody Drug Conjugates Breakdown Data by Company
- 8.2 China Antibody Drug Conjugates Breakdown Data by Type
- 8.3 China Antibody Drug Conjugates Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Antibody Drug Conjugates Breakdown Data by Company
- 9.2 Rest of World Antibody Drug Conjugates Breakdown Data by Type
- 9.3 Rest of World Antibody Drug Conjugates Breakdown Data by Application
- 9.4 Rest of World Antibody Drug Conjugates Breakdown Data by Countries
- 9.4.1 Rest of World Antibody Drug Conjugates Sales by Countries
- 9.4.2 Rest of World Antibody Drug Conjugates Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 F. Hoffman-La Roche
- 10.1.1 F. Hoffman-La Roche Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.1.4 Antibody Drug Conjugates Product Introduction
- 10.1.5 F. Hoffman-La Roche Recent Development
- 10.2 Novartis AG
- 10.2.1 Novartis AG Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.2.4 Antibody Drug Conjugates Product Introduction
- 10.2.5 Novartis AG Recent Development
- 10.3 Takeda Pharmaceutical
- 10.3.1 Takeda Pharmaceutical Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.3.4 Antibody Drug Conjugates Product Introduction
- 10.3.5 Takeda Pharmaceutical Recent Development
- 10.4 Pfizer
- 10.4.1 Pfizer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.4.4 Antibody Drug Conjugates Product Introduction
- 10.4.5 Pfizer Recent Development
- 10.5 Seattle Genetics
- 10.5.1 Seattle Genetics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.5.4 Antibody Drug Conjugates Product Introduction
- 10.5.5 Seattle Genetics Recent Development
- 10.6 Genentech
- 10.6.1 Genentech Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.6.4 Antibody Drug Conjugates Product Introduction
- 10.6.5 Genentech Recent Development
- 10.7 Immunogen
- 10.7.1 Immunogen Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.7.4 Antibody Drug Conjugates Product Introduction
- 10.7.5 Immunogen Recent Development
- 10.8 Progenics Pharmaceuticals
- 10.8.1 Progenics Pharmaceuticals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.8.4 Antibody Drug Conjugates Product Introduction
- 10.8.5 Progenics Pharmaceuticals Recent Development
- 10.9 Bayer Healthcare Pharmaceuticals
- 10.9.1 Bayer Healthcare Pharmaceuticals Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Antibody Drug Conjugates
- 10.9.4 Antibody Drug Conjugates Product Introduction
- 10.9.5 Bayer Healthcare Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Antibody Drug Conjugates Sales Channels
- 11.2.2 Antibody Drug Conjugates Distributors
- 11.3 Antibody Drug Conjugates Customers
12 Market Forecast
- 12.1 Global Antibody Drug Conjugates Sales and Revenue Forecast 2019-2025
- 12.2 Global Antibody Drug Conjugates Sales Forecast by Type
- 12.3 Global Antibody Drug Conjugates Sales Forecast by Application
- 12.4 Antibody Drug Conjugates Forecast by Regions
- 12.4.1 Global Antibody Drug Conjugates Sales Forecast by Regions 2019-2025
- 12.4.2 Global Antibody Drug Conjugates Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Antibody Drug Conjugates. Industry analysis & Market Report on Antibody Drug Conjugates is a syndicated market report, published as Global (United States, European Union and China) Antibody Drug Conjugates Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Antibody Drug Conjugates market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
